Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer

Fig. 4

Ruyiping inhibits breast cancer cells migration through miR-134. Transwell cell invasion assay of MDA-MB-231 and 4 T1 cells stimulated with RYP after transfected miR-134 mimics (A and B) or inhibitors (C and D). Quantification of migrated cells were shown in the right figures. *P < 0.05, **P < 0.01, and ***P < 0.001. P-values were determined by one-way analysis of variance. Data are mean ± standard error of the mean and are representative of three independent experiments

Back to article page